Clinical Trial Update: A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating interactions between an antiemetic medication and AMG 133 in adults with overweight or obesit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• AMG 133
• Antiemetic medication (unspecified)

Snippet

Sponsor: Amgen | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED